Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IRWD
#2703
Ironwood Pharmaceuticals, Inc. - Class A Common Stock
4.2
1
USD
-0.06%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-5.82%
Monthly Change
+11.67%
6 month change
-6.44%
Year Change
+468.92%
Previous Close
4.4
7
Open
4.2
1
Low
4.2
1
High
4.2
1
Volume
148
Markets
US Stock Market
Healthcare
Drug Manufacturers—Specialty & Generic
IRWD
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
Current
Key stats
Total common shares outstanding
161.82 M
162.43 M
162.68 M
163.06 M
164.61 M
164.61 M
Valuation ratios
Enterprise value
713.55 M
607.98 M
657.21 M
918.73 M
942.18 M
1.15 B
Price to earnings ratio
-7
-11.95
8.73
22.47
5.85
7.98
Price to sales ratio
0.74
0.37
0.64
1.85
1.67
2.28
Price to cash flow ratio
2.99
3.67
3.26
4.32
5.23
7.14
Price to book ratio
-0.19
-0.09
-0.18
-2.1
-0.57
-0.78
Enterprise value to EBITDA ratio
12.68
8
5.24
9.22
1.77
5.71
Profitability ratios
Return on assets %
-0.11
0.07
0.1
-0.01
0.09
0.09
Return on equity %
0.11
-0.08
-0.15
0.01
-0.19
-0.19
Return on invested capital %
-52.55
31.11
50.6
-40.33
55.89
55.89
Gross margin %
100
100
100
100
100
100
Operating margin %
-70.75
53.17
61.84
14.26
68.14
68.14
EBITDA margin %
-69.58
53.72
62.23
15.23
68.56
68.56
Net margin %
-90.87
27.69
32.84
-4.77
38.28
38.28
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
3.34
0.82
1.13
1.13
1.41
1.41
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.12
0.25
0.33
0.12
0.26
0.26
Solvency ratios
Debt to assets ratio
1.79
1.7
1.48
1.47
1.35
1.35
Debt to equity ratio
-1.75
-1.9
-2.21
-2.23
-2.69
-2.69
Long term debt to total assets ratio
0.61
0.58
0.5
1.47
1.35
1.35
Long term debt to total equity ratio
-0.6
-0.65
-0.76
-2.23
-2.69
-2.69
Per share metrics
Operating cash flow per share
0.12
-0.09
0.27
0.46
0.03
0.67
EBIT per share
-0.18
0.26
0.42
0.04
0.44
1.16
EBITDA per share
-0.18
0.26
0.43
0.04
0.44
1.17
Total debt per share
3.63
3.3
3.29
3.59
3.51
3.51
Cash per share
0.67
0.53
0.79
1.32
1.32
1.32
Net current asset value per share
1
1.08
1.54
1.68
1.99
1.99
Tangible book value per share
-2.08
-1.74
-1.49
-1.61
-1.3
-1.3
Working capital per share
0.7
-0.23
0.18
0.2
0.58
0.58
Book value per share
-2.08
-1.74
-1.49
-1.61
-1.3
-1.3
News
Ironwood: Linzess Buys Time, But Apraglutide's rNPV Doesn't Close The Gap (NASDAQ:IRWD)
BioCryst (BCRX) Surges 8.1%: Is This an Indication of Further Gains?
4 Defensive Stocks to Take Refuge in as Tech Sell-off Continues
Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker
5 Small Drug Stocks to Invest in Amid a Biotech Comeback
Can Linzess Continue Driving IRWD's Revenue Growth Through 2026?
IRWD's Linzess Wins FDA Nod for Expanded Pediatric Constipation Use
Ironwood Pharmaceuticals: A Contrarian Buy Opportunity (NASDAQ:IRWD)
Ironwood Pharmaceuticals, Inc: Still A Profitable Opportunity (NASDAQ:IRWD)
Ironwood Stock Down Despite Q1 Earnings and Revenue Beat
Ironwood Pharmaceuticals, Inc. (IRWD) Q1 2026 Earnings Call Transcript
Ironwood Pharmaceuticals (IRWD) Tops Q1 Earnings and Revenue Estimates